<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04829175</url>
  </required_header>
  <id_info>
    <org_study_id>ESC_2020_03</org_study_id>
    <nct_id>NCT04829175</nct_id>
  </id_info>
  <brief_title>Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry</brief_title>
  <official_title>A Long Term Prospective Observational Post Market Clinical Follow-Up (PMCF) Registry of Ethicon Gynecare Pelvic Mesh Products for The Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this post market, clinical registry is to evaluate the performance of the&#xD;
      products of the TVT family of products or vaginal vault or uterine prolapse repair (with&#xD;
      laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS&#xD;
      Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 30, 2021</start_date>
  <completion_date type="Anticipated">February 27, 2034</completion_date>
  <primary_completion_date type="Anticipated">August 29, 2033</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stress Urinary Incontinence(SUI)- Cough Stress Test(CST) Assessment Change</measure>
    <time_frame>Post-surgery through registry completion, approximately 5-10 yrs</time_frame>
    <description>Objective cure (success) approximately 5-10 years after surgery, defined as a negative standardized cough stress test (CST)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pelvic Organ Prolapse (POP)- Physical Examination with Pelvic Organ Prolapse Quantification (POP-Q) Assessment Change</measure>
    <time_frame>Post-surgery through registry completion, approximately 5-10 yrs</time_frame>
    <description>Objective cure (success) approximately 5-10 years after surgery, defined as the absence of prolapse beyond the hymen as determined by a physical examination with POP-Q</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>SUI: International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF)</measure>
    <time_frame>Baseline and post-surgery through registry completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SUI: Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)</measure>
    <time_frame>Baseline and post-surgery through registry completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SUI: Patient Global Impression of Improvement questionnaire (PGI-I)</measure>
    <time_frame>Post-surgery through registry completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SUI: Wong-Baker FACES Pain Rating Scale</measure>
    <time_frame>Post-surgery through registry completion, approximately 10 yrs</time_frame>
    <description>To assess pain on a scale from 0 (no pain) to 10 (worst pain) related to registry device or procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP: Pelvic Floor Distress Inventory (PFDI-20) Questionnaire</measure>
    <time_frame>Baseline and post-surgery through registry completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP: Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)</measure>
    <time_frame>Baseline and post-surgery through registry completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP: Patient Global Impression of Improvement questionnaire (PGI-I)</measure>
    <time_frame>Post-surgery through registry completion, approximately 10 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POP: Wong-Baker FACES Pain Rating Scale</measure>
    <time_frame>Post-surgery through registry completion, approximately 10 yrs</time_frame>
    <description>To assess pain on a scale from 0 (no pain) to 10 (worst pain) related to registry device or procedure (if applicable)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <condition>Pelvic Organ Prolapse</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intervention</intervention_name>
    <description>There is no intervention, beyond necessary clinical care, in this registry. The surgical procedures being performed within the registry are identical to the surgical procedures patients would receive as part of SOC.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients ≥ 21 years of age with:&#xD;
&#xD;
          -  A diagnosis of SUI, resulting from urethral hypermobility and/or intrinsic sphincter&#xD;
             deficiency AND/OR&#xD;
&#xD;
          -  A diagnosis of vaginal vault or uterine prolapses where surgical treatment&#xD;
             (sacrocolposuspension or sacrocolpopexy, laparotomic or laparoscopic approach&#xD;
             including robotic assisted) is warranted AND&#xD;
&#xD;
          -  Are scheduled to have surgical treatment using an Ethicon Gynecare Pelvic Mesh Product&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients who satisfy all of the following criteria will be considered eligible for&#xD;
        enrollment in this registry:&#xD;
&#xD;
        SUI&#xD;
&#xD;
          1. Stress urinary incontinence symptoms&#xD;
&#xD;
          2. Urodynamic stress incontinence confirmed with urodynamic testing&#xD;
&#xD;
          3. Female patient ≥ 21 years of age&#xD;
&#xD;
          4. Desired surgical correction of SUI using synthetic pubo-urethral vaginal sling&#xD;
&#xD;
          5. Planned surgery for primary SUI&#xD;
&#xD;
          6. Patient able and willing to participate in follow-up&#xD;
&#xD;
          7. Patient or authorized representative has signed the approved Informed consent POP&#xD;
&#xD;
        1. Uterine or vaginal vault prolapse symptoms 2. Urodynamic testing (optional) 3. Female&#xD;
        patient ≥ 21 years of age 4. Desired surgical correction of POP using synthetic mesh 5.&#xD;
        Planned surgery for uterine or vaginal vault prolapse with or without concomitant SUI&#xD;
        surgery 6. Patient able and willing to participate in follow-up 7. Patient or authorized&#xD;
        representative has signed the approved Informed consent&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Patients meeting any of the following criteria will be considered not eligible for&#xD;
        enrollment in this registry:&#xD;
&#xD;
          1. Physical or psychological condition which would impair registry participation or are&#xD;
             unwilling or unable to participate in all required registry visits and are unable to&#xD;
             complete the questionnaires&#xD;
&#xD;
          2. Any pre-operative or intra-operative findings identified by the surgeon that may&#xD;
             preclude the use of registry products&#xD;
&#xD;
          3. History of previous synthetic, biologic or fascial sub-urethral sling (SUI) or pelvic&#xD;
             mesh (POP)&#xD;
&#xD;
          4. Pregnancy or plans for future pregnancy&#xD;
&#xD;
          5. History of bleeding diathesis or current anti-coagulation therapy which cannot be&#xD;
             suspended peri-operatively according to site's standard practice&#xD;
&#xD;
          6. Current genitourinary fistula or urethral diverticulum&#xD;
&#xD;
          7. Reversible cause of incontinence (i.e. drug effect) for SUI only&#xD;
&#xD;
          8. Severe vaginal atrophy&#xD;
&#xD;
          9. History of pelvic irradiation therapy&#xD;
&#xD;
         10. Contraindication to surgery&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female patients ≥ 21 years of age</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni A Tommaselli, MD</last_name>
    <role>Study Director</role>
    <affiliation>Ethicon, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christine Romanowski</last_name>
    <phone>908-218-3156</phone>
    <email>cromanow@its.jnj.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UPMC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>General University Hospital</name>
      <address>
        <city>Prague</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Hillerod</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Jeanne de Flandres</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Tubingen</name>
      <address>
        <city>Tubingen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Żelazna Medical Center</name>
      <address>
        <city>Warsaw</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Institute</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Poland</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 17, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Stress Urinary Incontinence</keyword>
  <keyword>Pelvic Organ Prolapse</keyword>
  <keyword>SUI</keyword>
  <keyword>POP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
    <mesh_term>Prolapse</mesh_term>
    <mesh_term>Pelvic Organ Prolapse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Johnson &amp; Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.</ipd_description>
    <ipd_url>http://yoda.yale.edu</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

